Arun V J: Don’t Miss TRANSCON 2026 – A Direct Pathway Into India’s Clinical and Institutional Network
Arun V J, The Leader of Transfusion Medicine at Malabar Medical College, shared a post on LinkedIn:
”If you’re in Blood Banking, Transfusion Medicine, MedTech, IVD, diagnostics, or healthcare marketing, India is no longer a ‘next’ market – it’s a current growth priority.
With one of the fastest-expanding healthcare ecosystems globally, the real question is not if you enter – but how effectively you engage the right stakeholders.
Welcome to India’s largest gathering of Blood Banking/Transfusion Medicine Professionals.
TRANSCON 2026 (18–20 September | Kochi, India) is designed for exactly that.
It brings together:
- Clinicians and transfusion specialists
- Policy influencers and program leaders
- Hospital decision-makers and academic experts
- Industry partners across blood banking, diagnostics, and advanced therapies
This is not a conventional conference or passive exhibition.
It is a working interface where:
- technologies are critically evaluated – not just displayed
- procurement pathways and collaborations begin
- market understanding moves from theory to real conversations
With 1000+ delegates and 100+ national and international faculty, the engagement is both high-density and decision-focused.
If your organisation is working in:
- Blood Banking and Transfusion Medicine
- Apheresis and Cellular Therapies
- Diagnostics and Immunohematology
- AI, Automation and Digital Health
- Plasma, Fractionation and Biologics
This platform offers a direct pathway into India’s clinical and institutional network.
The attached brochure outlines:
- Scientific tracks and emerging themes
- Pre-conference workshops (AI, apheresis, transplant immunology, regenerative medicine)
- Industry engagement opportunities
India is scaling rapidly across healthcare delivery, infrastructure, and technology adoption.
TRANSCON 2026 is where global innovation meets this scale.
If India is part of your strategic roadmap, this is a high-value touchpoint.”

Stay updated with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia